Recognized charges

[Table of Contents](#i754bc30884284e56b9b1a914458fa36e_7)securities that would have a dilutive effect on EPS. All stock options with an exercise price lower than the average market share price of our common stock for the period are assumed to have a dilutive effect on EPS. The dilutive share base for the three months ended September 30, 2022 excluded approximately 467,770 shares related to stock options that would have an antidilutive effect on the computation of diluted earnings per share. Due to a net loss for the nine months ended September 30, 2022, no incremental shares are included in the computation of diluted earnings per share because the effect would be antidilutive. Approximately 1.9 million shares related to stock options and share-based awards were therefore excluded from the dilutive share base for the nine months ended September 30, 2022. The dilutive share base for the three and nine months ended September 30, 2021 excluded approximately 234,813 shares related to stock options that would have an antidilutive effect on the computation of diluted earnings per share.   
The effect of the potential shares needed to settle the conversion spread on the Convertible Notes is included in diluted EPS if the effect is dilutive. The effect depends on the market share price of our common stock at the time of conversion and would be dilutive if the average market share price of our common stock for the period exceeds the conversion price. For the three and nine months ended September 30, 2022, the Convertible Notes were not included in the computation of diluted EPS as the effect would have been anti-dilutive. Further, the effect of the related capped call transactions is not included in the computation of diluted EPS as it is always anti-dilutive.  
The following table sets forth the computation of diluted weighted-average number of shares outstanding for the three and nine months ended September 30, 2022 and 2021:

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Three Months Ended |  | Nine Months Ended |
|  | September 30, 2022 |  | September 30, 2021 |  | September 30, 2022 |  | September 30, 2021 |
|  |  |  |  |  |  |  |  |
|  | (in thousands) |
|  |  |  |  |  |  |  |  |
| Basic weighted-average number of shares outstanding | 275,030  |  |  | 291,502  |  |  | 278,411  |  |  | 294,262  |  |
| Plus: Dilutive effect of stock options and other share-based awards | 405  |  |  | 1,005  |  |  | —  |  |  | 1,159  |  |
| Diluted weighted-average number of shares outstanding | 275,435  |  |  | 292,507  |  |  | 278,411  |  |  | 295,421  |  |

  
NOTE 12 - SUPPLEMENTAL BALANCE SHEET INFORMATION  
Cash, cash equivalents and restricted cash  
A reconciliation of the amounts of cash and cash equivalents and restricted cash in the consolidated balance sheets to the amount in the consolidated statements of cash flows is as follows:  


|  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |
|  | September 30, 2022 |  | December 31, 2021 |
|  |  |  |  |
|  | (in thousands) |
| Cash and cash equivalents | $ | 1,993,840  |  |  | $ | 1,979,308  |  |
| Restricted cash included in prepaid expenses and other current assets | 132,458  |  |  | 143,715  |  |
| Cash included in assets held for sale | 31,195  |  |  | —  |  |
| Cash, cash equivalents and restricted cash shown in the statement of cash flows | $ | 2,157,493  |  |  | $ | 2,123,023  |  |

  
Long-lived assets  
As a result of actions taken in the third quarter of 2022 to further reduce our facility footprint in certain markets around the world, we recognized charges of $27.7 million, primarily related to certain lease right-of-use assets, leasehold improvements, furniture and fixtures and equipment, to reduce the carrying amount of each asset group to estimated fair value. The charges were presented within selling, general and administrative expenses in our consolidated statement of income for the 26
